Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC
Condition: Metastatic Castration-Resistant Prostate Cancer Interventions: Drug: CORT125281; Drug: Enzalutamide (Xtandi) Sponsor: Corcept Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials